NeueHealth Statistics
Total Valuation
NeueHealth has a market cap or net worth of $50.82 million. The enterprise value is $327.60 million.
Market Cap | 50.82M |
Enterprise Value | 327.60M |
Important Dates
The next confirmed earnings date is Wednesday, May 8, 2024, before market open.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NeueHealth has 8.05 million shares outstanding. The number of shares has increased by 1.09% in one year.
Shares Outstanding | 8.05M |
Shares Change (YoY) | +1.09% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.04 |
Forward PS | 0.05 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.28 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.78
Current Ratio | 0.78 |
Quick Ratio | 0.18 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -29.18 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -38.40% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $927,158 |
Profits Per Employee | -$958,945 |
Employee Count | 1,252 |
Asset Turnover | 0.37 |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.43M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.62% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -61.62% |
50-Day Moving Average | 7.20 |
200-Day Moving Average | 8.48 |
Relative Strength Index (RSI) | 36.46 |
Average Volume (30 Days) | 22,488 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NeueHealth had revenue of $1.16 billion and -$1.20 billion in losses. Loss per share was -$150.94.
Revenue | 1.16B |
Gross Profit | 164.22M |
Operating Income | -577.00M |
Pretax Income | -1.15B |
Net Income | -1.20B |
EBITDA | -1.09B |
EBIT | -1.11B |
Loss Per Share | -$150.94 |
Balance Sheet
The company has $93.56 million in cash and $370.35 million in debt, giving a net cash position of -$276.78 million or -$34.37 per share.
Cash & Cash Equivalents | 93.56M |
Total Debt | 370.35M |
Net Cash | -276.78M |
Net Cash Per Share | -$34.37 |
Equity / Book Value | -1.26B |
Book Value Per Share | -156.93 |
Working Capital | -302.33M |
Cash Flow
In the last 12 months, operating cash flow was -$2.73 billion and capital expenditures -$2.90 million, giving a free cash flow of -$2.73 billion.
Operating Cash Flow | -2.73B |
Capital Expenditures | -2.90M |
Free Cash Flow | -2.73B |
FCF Per Share | -$343.15 |
Margins
Gross margin is 14.15%, with operating and profit margins of -49.71% and -103.43%.
Gross Margin | 14.15% |
Operating Margin | -49.71% |
Pretax Margin | -99.32% |
Profit Margin | -103.43% |
EBITDA Margin | -93.94% |
EBIT Margin | -96.03% |
FCF Margin | -235.13% |
Dividends & Yields
NeueHealth does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.09% |
Shareholder Yield | -1.09% |
Earnings Yield | -2,362.38% |
FCF Yield | -5,370.65% |
Analyst Forecast
The average price target for NeueHealth is $8.00, which is 26.78% higher than the current price. The consensus rating is "Hold".
Price Target | $8.00 |
Price Target Difference | 26.78% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NeueHealth has an Altman Z-Score of -7.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -7.25 |
Piotroski F-Score | 2 |